![Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS](https://www.pnas.org/cms/10.1073/pnas.0709443104/asset/bbf9782b-ded9-4924-a0e7-46983c97352b/assets/graphic/zpq0480784870005.jpeg)
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS
![Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS](https://www.pnas.org/cms/10.1073/pnas.0709443104/asset/b115d334-2234-40e2-84e8-f59c212f2e30/assets/graphic/zpq0480784870004.jpeg)
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS
![Obatoclax Induces G1/G0‐Phase Arrest via p38/p21waf1/Cip1 Signaling Pathway in Human Esophageal Cancer Cells - Zhong - 2014 - Journal of Cellular Biochemistry - Wiley Online Library Obatoclax Induces G1/G0‐Phase Arrest via p38/p21waf1/Cip1 Signaling Pathway in Human Esophageal Cancer Cells - Zhong - 2014 - Journal of Cellular Biochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9ba3cb7c-88b7-46f9-ab0d-2b0fb7c0e2fd/jcb24829-fig-0002-m.png)
Obatoclax Induces G1/G0‐Phase Arrest via p38/p21waf1/Cip1 Signaling Pathway in Human Esophageal Cancer Cells - Zhong - 2014 - Journal of Cellular Biochemistry - Wiley Online Library
![Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling | BMC Cancer | Full Text Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-015-1929-y/MediaObjects/12885_2015_1929_Fig1_HTML.gif)
Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling | BMC Cancer | Full Text
![IJMS | Free Full-Text | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells | HTML IJMS | Free Full-Text | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells | HTML](https://www.mdpi.com/ijms/ijms-18-00044/article_deploy/html/images/ijms-18-00044-g002.png)
IJMS | Free Full-Text | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells | HTML
![Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis - Clinical Lymphoma, Myeloma and Leukemia Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/427934/2969433/si2.gif)
Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis - Clinical Lymphoma, Myeloma and Leukemia
A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia | PLOS ONE
![IJMS | Free Full-Text | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells | HTML IJMS | Free Full-Text | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells | HTML](https://www.mdpi.com/ijms/ijms-18-00044/article_deploy/html/images/ijms-18-00044-g003a.png)
IJMS | Free Full-Text | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells | HTML
![Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK | Cell Death & Disease Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcddis.2010.86/MediaObjects/41419_2010_Article_BFcddis201086_Fig1_HTML.jpg)
Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK | Cell Death & Disease
![Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer - Journal of Thoracic Oncology Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2039850626/2053443835/gr1.jpg)
Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer - Journal of Thoracic Oncology
![Pharmacodynamic biomarker analysis from the phase 1 trial of obatoclax... | Download Scientific Diagram Pharmacodynamic biomarker analysis from the phase 1 trial of obatoclax... | Download Scientific Diagram](https://www.researchgate.net/profile/Jeffrey-Cummings-3/publication/51031420/figure/fig2/AS:601223845650433@1520354343479/Pharmacodynamic-biomarker-analysis-from-the-phase-1-trial-of-obatoclax-in-combination.png)
Pharmacodynamic biomarker analysis from the phase 1 trial of obatoclax... | Download Scientific Diagram
![Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS](https://www.pnas.org/cms/10.1073/pnas.0709443104/asset/b041720a-fa09-430b-b120-995d3b941cb4/assets/graphic/zpq0480784870001.jpeg)